Agree...if non us FDA’s are truly inclined at this point to approve some thing why not go with the 28 day. Because if they really are interested in Leronlimab The most they could ask for after that is a follow up at 42 but in the meantime Nader would have a bargaining chip and shareholders could have some kind of answer either just before or just after Christmas.